Lipid profiles reveal sex differences in type 2 diabetes
Type 2 diabetes, or T2D, is a metabolic disorder that affects global communities disproportionally. For example, South Asians face a particularly high risk. Changes in lipid species affect T2D, but scientists have not identified any reliable lipid biomarkers. Fatty acids, or FAs, are the major components of many lipids, and they can be potential lipid biomarkers. However, conflicting findings have left unclear how essential FAs relate to T2D development.
In a recent study in the Journal of Lipid Research, Madhusmita Rout and a team of researchers at the University of Oklahoma Health Sciences Center investigated the lipid profiles of individuals from a well-characterized cohort of Asian Indians. They found that in T2D, levels of two key cell membrane components — sphingomyelin and phosphatidylcholines — decreased, while free FAs and lysophosphatidylcholines, or LPCs, increased. After adjusting for age, sex and body mass index, or BMI, they saw significant increases in several essential FAs, such as the omega-6 FA arachidonic acid and the omega-3 FA docosahexaenoic acid. However, in obese individuals, most omega-3 and omega-6 FAs were reduced two- to six-fold. The team also observed sex- and age-related lipid differences. For example, one LPC type was elevated in men of all ages but rose in women only after menopause.
Ultimately, this study identified potentially useful lipid biomarkers that could possibly affect the development of T2D and obesity. Future directions include clarifying the relationship between omega FAs and T2D, as well as the role of essential FAs in human metabolic diseases.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Redefining lipid biology from droplets to ferroptosis
James Olzmann will receive the ASBMB Avanti Award in Lipids at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.
Women’s health cannot leave rare diseases behind
A physician living with lymphangioleiomyomatosis and a basic scientist explain why patient-driven, trial-ready research is essential to turning momentum into meaningful progress.
Life in four dimensions: When biology outpaces the brain
Nobel laureate Eric Betzig will discuss his research on information transfer in biology from proteins to organisms at the 2026 ASBMB Annual Meeting.
Fasting, fat and the molecular switches that keep us alive
Nutritional biochemist and JLR AE Sander Kersten has spent decades uncovering how the body adapts to fasting. His discoveries on lipid metabolism and gene regulation reveal how our ancient survival mechanisms may hold keys to modern metabolic health.
Redefining excellence to drive equity and innovation
Donita Brady will receive the ASBMB Ruth Kirschstein Award for Maximizing Access in Science at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.
Mining microbes for rare earth solutions
Joseph Cotruvo, Jr., will receive the ASBMB Mildred Cohn Young Investigator Award at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.